Neuroblastoma origin and therapeutic targets for immunotherapy
IV Kholodenko, DV Kalinovsky… - Journal of …, 2018 - Wiley Online Library
Neuroblastoma is a pediatric solid cancer of heterogeneous clinical behavior. The unique
features of this type of cancer frequently hamper the process of determining clinical …
features of this type of cancer frequently hamper the process of determining clinical …
[HTML][HTML] Ovarian cancer stem cells and targeted therapy
Background Ovarian cancer has the highest ratio of mortality among gynecologic
malignancies. Chemotherapy is one of the most common treatment options for ovarian …
malignancies. Chemotherapy is one of the most common treatment options for ovarian …
[HTML][HTML] Tumoral heterogeneity in neuroblastoma
RL Gomez, S Ibragimova, R Ramachandran… - … et Biophysica Acta (BBA …, 2022 - Elsevier
Neuroblastoma is a solid, neuroendocrine tumor with divergent clinical behavior ranging
from asymptomatic to fatal. The diverse clinical presentations of neuroblastoma are directly …
from asymptomatic to fatal. The diverse clinical presentations of neuroblastoma are directly …
[HTML][HTML] Cancer stem cells in neuroblastoma: expanding the therapeutic frontier
Neuroblastoma (NB) is the most common extracranial solid tumor often diagnosed in
childhood. Despite intense efforts to develop a successful treatment, current available …
childhood. Despite intense efforts to develop a successful treatment, current available …
Strategies for isolating and enriching cancer stem cells: well begun is half done
J Duan, W Qiu, S Xu, B Wang, X Ye, Y Ping… - Stem cells and …, 2013 - liebertpub.com
Cancer stem cells (CSCs) constitute a subpopulation of cancer cells that have the potential
for self-renewal, multipotent differentiation, and tumorigenicity. Studies on CSC biology and …
for self-renewal, multipotent differentiation, and tumorigenicity. Studies on CSC biology and …
ALDH1 in combination with CD44 as putative cancer stem cell markers are correlated with poor prognosis in urothelial carcinoma of the urinary bladder
H Keymoosi, E Gheytanchi, M Asgari… - Asian Pacific Journal …, 2014 - koreascience.kr
Background: The aldehyde dehydrogenase 1 family member A1 (ALDH1A1) is one of the
promising markers for identifying cancer stem cells in many cancer types, along with other …
promising markers for identifying cancer stem cells in many cancer types, along with other …
[HTML][HTML] Ovarian Cancer and Cancer Stem Cells—Cellular and Molecular Characteristics, Signaling Pathways, and Usefulness as a Diagnostic Tool in Medicine and …
Simple Summary Ovarian cancer is still a high-risk, metastatic disease, often diagnosed at a
late stage. Difficulties in its treatment are associated with high resistance to chemotherapy …
late stage. Difficulties in its treatment are associated with high resistance to chemotherapy …
Analysis of N‐ and O‐linked site‐specific glycosylation by ion mobility mass spectrometry: State of the art and future directions
M Girgis, G Petruncio, P Russo, S Peyton, M Paige… - …, 2024 - Wiley Online Library
Glycosylation, the major post‐translational modification of proteins, significantly increases
the diversity of proteoforms. Glycans are involved in a variety of pivotal structural and …
the diversity of proteoforms. Glycans are involved in a variety of pivotal structural and …
Co-expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas
E Kalantari, M Asgari, S Nikpanah, N Salarieh… - Pathology & Oncology …, 2017 - Springer
Cancer stem cells (CSCs) are the main players of prostate tumorigenesis thus;
characterization of CSCs can pave the way for understanding the early detection, drug …
characterization of CSCs can pave the way for understanding the early detection, drug …
High GD2 expression defines breast cancer cells with enhanced invasiveness
Introduction Breast cancer is the most frequently diagnosed cancer among women. Cancer
stem cells (CSCs) are suggested to be responsible for tumor initiation, progression …
stem cells (CSCs) are suggested to be responsible for tumor initiation, progression …